Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Astrocytia Consulting ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   17.5% 7.1% 26.4% 4.8% 22.0% 5.5% 20.3% 20.3%   Credit score (0-100)   10 34 2 44 3 41 5 5   Credit rating   B BBB B BBB B BBB B B   Credit limit (kDKK)   0.0 0.0 -0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   932 7,233 305 7,873 96.0 2,989 0.0 0.0   EBITDA   89.4 3,080 -3,421 5,509 -5,194 1,186 0.0 0.0   EBIT   88.7 3,005 -3,551 5,381 -5,280 998 0.0 0.0   Pre-tax profit (PTP)   79.1 2,996.4 -3,607.5 5,288.6 -5,322.6 728.4 0.0 0.0   Net earnings   46.6 2,332.3 -2,822.9 4,107.3 -4,177.0 554.4 0.0 0.0   Pre-tax profit without non-rec. items   79.1 2,996 -3,608 5,289 -5,323 728 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   26.9 337 208 79.8 103 72.5 0.0 0.0   Shareholders equity total   49.9 2,382 -441 3,667 -510 44.0 -1,199 -1,199   Interest-bearing liabilities   2.1 0.9 754 186 2,286 1,667 1,199 1,199   Balance sheet total (assets)   389 4,234 2,099 6,786 2,786 2,694 0.0 0.0   Net Debt   -29.7 -227 754 -2,937 2,253 1,666 1,199 1,199     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   932 7,233 305 7,873 96.0 2,989 0.0 0.0   Gross profit growth   2,220.4% 675.6% -95.8% 2,479.0% -98.8% 3,013.4% -100.0% 0.0%   Employees   3 12 9 6 7 4 0 0   Employee growth %   200.0% 300.0% -25.0% -33.3% 16.7% -42.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   389 4,234 2,099 6,786 2,786 2,694 0 0   Balance sheet change%   1,771.8% 988.4% -50.4% 223.3% -58.9% -3.3% -100.0% 0.0%   Added value   89.4 3,079.9 -3,421.3 5,509.4 -5,151.6 1,185.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   26 235 -259 -256 714 548 -1,614 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.5% 41.5% -1,163.2% 68.4% -5,498.4% 33.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   44.8% 130.1% -104.8% 115.5% -104.1% 34.1% 0.0% 0.0%   ROI %   160.3% 210.2% -186.5% 219.8% -170.7% 51.1% 0.0% 0.0%   ROE %   174.8% 191.8% -126.0% 142.5% -129.5% 39.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   12.8% 56.3% -17.4% 54.0% -15.5% 1.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -33.2% -7.4% -22.0% -53.3% -43.4% 140.5% 0.0% 0.0%   Gearing %   4.2% 0.0% -171.2% 5.1% -447.9% 3,792.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   141.3% 758.1% 15.5% 20.3% 6.2% 14.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.2 2.7 0.8 2.1 0.6 0.4 0.0 0.0   Current Ratio   1.2 2.7 0.8 2.1 0.6 0.4 0.0 0.0   Cash and cash equivalent   31.8 228.3 0.0 3,123.5 32.6 1.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   66.2 2,427.6 -362.6 3,565.7 -1,188.6 -1,325.5 -599.4 -599.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   30 257 -380 918 -736 296 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   30 257 -380 918 -742 296 0 0   EBIT / employee   30 250 -395 897 -754 250 0 0   Net earnings / employee   16 194 -314 685 -597 139 0 0